Some studies using an AD‐prone model mouse showed that oral administration of L. sakei KABP‐065 significantly reduces AD severity [37], has a strong inhibitory effect against S. aureus, and reduces serum IgE production [20]. The gene discussed is IGHE; the disease is Alzheimer disease.